Back to search
FDAFDA · Food and drugs·Recall number D-0075-2027

Metoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 51079-886-20.

Published November 4, 2026 · Recall initiated: October 6, 2026

Summary

FDA records drug Class II recall D-0075-2027, published November 4, 2026 and initiated October 6, 2026. Recalling firm: Safecor Health, LLC; Status: Ongoing; Lot: Lot # 3116509, Expiry: 07/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Manufacturer is recalling batches due to co-mingled tablet.

What to do

Voluntary: Firm initiated · E-Mail

Get an email if METOCLOPRAMIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METOCLOPRAMIDE
Manufacturer
Safecor Health, LLC
Distributor
US Nationwide
Lot
Lot # 3116509, Expiry: 07/31/2027.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 51079-886-20. recalled?

Yes. FDA published recall D-0075-2027 on November 4, 2026. Reported hazard: Manufacturer is recalling batches due to co-mingled tablet.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METOCLOPRAMIDE.